definiens: shall mean Know - How Controlled by [COMPANY] or its Affiliates ( a ) as of the Effective Date,(b ) at any time during the [ * * ] period following the Effective Date, ( c ) during the term of this Agreement, if such Know - How Controlled by [COMPANY] or its Affiliates is licensed from Sirna Therapeutics, Inc., or ( d ) at any time if such Know - Howis within the [COMPANY] Collaboration Target Specific Intellectual Property and not assigned to [COMPANY] pursuant to Section6.3(b ), in each case that is necessary or useful for the Development, Commercialization or Manufacture of RNAiCompounds, RNAi Products, and/or Licensed Products ; but excluding ( i ) any scientific, regulatory, pre - clinical or clinicalinformation or data relating and useful solely to specific Indications of particular RNAi Products, ( ii ) any marketing, financial, commercial or personnel information and plans or ( iii ) Delivery Know - How . For purposes of clarity, Broad RNAiKnow - How shall not include Know - How to the extent specifically and solely related to and useful for microRNAs, microRNA antagonists, or microRNA mimics . Notwithstanding the foregoing or anything to the contrary in thisAgreement, except as otherwise expressly provided in Section 6.3, in the Research Collaboration Plan, in the DeliveryCollaboration Plan or in the Technology Transfer Plan, [COMPANY] shall not have any obligation to disclose to Takedaparticular [ * * ] of RNAi Products